New Research Program Targets Porcine Circovirus
US - Porcine Circovirus Associated Diseases (PCVAD) such as PMWS and PDNS have been wreaking havoc in Europe for a number of years now, and are becoming a growing threat to the North American industry. In an effort to share information on the subject,...

Scourmune® Improves Compliance in Prevention of Scours with Bilingual English-Spanish Label
US - In response to customer feedback, SPAH has announced it will be discontinuing the Scourmune® 25 dose vaccine (NDC# 0061-056206).

2006 PRRS Research Awards from BIVI Focus on Detection, Diagnostic Protocols
MISSOURI - Research studies involving the transmission and monitoring of Porcine Reproductive and Respiratory Syndrome (PRRS) are the areas of concentration for the 2006 Advancement in PRRS Research Awards sponsored by Boehringer Ingelheim Vetmedica,...

Boehringer Ingelheim offers combination discount for oral vaccines in USA
USA – Boehringer Ingelheim Vetmedica, Inc., (BIVI) have announced in the US they are offering a 20 percent discount from the list price on all orders of Ingelvac® ERY-ALC for control of swine erysipelas, when shipped with an equal dose amount of Enterisol®...

Boehringer Ingelheim Expands Swine Team
US - Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the promotion of Sara Balvanz to sales representative and the addition of Abby Lauenroth as corporate account trainer for the company’s swine division.

2006 Brings First Hypor Dealership to USA
US - Hypor is pleased to announce the signing of a joint venture dealership between Hypor Inc and American Swine Genetics. Hypor USA, the name of the venture which will be based in Olivia, Minnesota, becomes the first and only Hypor dealership in the...

Schering-Plough Animal Health Commemorates 50th Anniversary
GLOBAL - Schering-Plough Animal Health Corp. (SPAH), a global leader in advancing the health and welfare of animals, is celebrating its 50th anniversary today.

Swine Vets out-earn colleagues, study shows
CHICAGO - Veterinarians concentrating in swine medicine gross nearly $110,000 annually, leading all practitioner categories and disproving a widespread belief that food animal DVMs rank low in wage potential.

Major New Advancement in the Control of Erysipelas and Mycoplasma Pneumonia introduced
US - Schering-Plough Animal Health Corporation (Schering-Plough) today introduced M+Rhusigen™, a new vaccine containing major advancements to help swine producers control the devastating impact of both Erysipelas and Mycoplasma Pneumonia.

DAHS Virkon® S proves highly effective and economic against PRRS virus
US - DuPont Animal Health Solutions' broad spectrum disinfectant, DAHS Virkon® S, has proved highly potent against the PRRS virus at the high dilution of 1:500. Recent tests, carried out by a leading independent laboratory in the USA proved that DAHS...

Hypor Welcomes General Manager for the Americas
US - Hypor announced a new General Manager, Hypor America today. Gerjan Van Alst is transferring from Hypor in Holland to take over the responsibilities of Raf Beeren, who is returning to Holland as Hypor's Project Manager.

Jury awards Boehringer-Ingelheim $6.905 million plus interest
US - A New Jersey jury has today rendered a decision in Schering-Plough's animal vaccine infringement suit.

Computer-modeling tool to forecast ROI of health programs
US - Properly managed vaccines and antibiotics are essential for managing the toughest diseases of swine. But let's face it, sometimes the payback on specific products or programs can be difficult to measure.

Schering-Plough's VeriSource To Revolutionize Livestock Management
US - Informatica Corporation announced that Global Animal Management Inc., a subsidiary of Schering-Plough Corporation, is successfully powering its industry-leading animal lifecycle management solution, VeriSource, using Informatica's enterprise...

SIV Gets More Complicated - Diagnosis and Treatment Include Larger Number of Virus Strains
US - Swine influenza virus (SIV) used to be a seasonal problem - pigs got sick in the fall and winter and then they got over it. Today's mix of SIV strains has turned swine flu into a year-round problem for swine producers.

Schering-Plough launches first trivalent SIV vaccine
US - Schering-Plough Animal Health has launched Maxivac® Excell 3, the industry's first trivalent vaccine for the costly swine influenza virus (SIV).

Pfizer and Pharmacia Combine Operations
US - Pfizer Inc and Pharmacia Corporation combined operations today, bringing together two of the world’s fastest-growing and most innovative companies.

New-Generation Vaccines Offer Flexibility in Control of SIV
US - Two new-generation monovalent swine influenza vaccines — MaxiVac® H1N1 and MaxiVac® H3N2 — have been launched by Schering-Plough Animal Health Corporation and will bring added flexibility to swine producers and vets.